• Home
• Reports
• Companies

• Partnering Search
• Profiling
• Deal Negotiation

• Out-licensing
• In-licensing
• Services

• PL Intelligence
• Deals review
• Industry news

• Press releases
• Events
• Newsletter

Latest: Watch here for details of new products and services.

Pharmalicensing
is a division of
UTEK Europe Ltd

— AMPFING, Germany, October 26

AMPFING, Germany, October 26 /PRNewswire/ -- German based LIFEBRIDGE AG has received clearance from the U.S. Food and Drug Administration (FDA) for a compact, lightweight, mobile heart-lung machine, a first for any manufacturer worldwide.

The novel device received CE certification for Germany and Europe in 2008, and now FDA clearance makes the mobile LIFEBRIDGE(R) available for use as a cardiopulmonary support system in the important US market as well. Weighing a mere 38.5 lbs (17.5kg), the LIFEBRIDGE can be used to assume the function or the heart and lungs anytime, anywhere. Even on battery power. This allows the patient to receive oxygen and circulatory support even during the most critical situations.

The LIFEBRIDGE(R) provides novel therapy that can be used by cardiologists, cardiovascular surgeons and ER physicians to treat patients in immediate need of cario-pulmonary support.

This device can help stabilize the patient's condition and can assume the functions of the heart and lung completely in emergency cases. The LIFEBRIDGE(R) can provide full heart and lung support even when operating on battery power.

The LIFEBRIDGE is the first compact, mobile heart lung machine cleared by FDA.

We are aware of the interest of our American colleagues and plan to introduce this life-saving technology to key US centers soon, states Michael Huf, Head of Sales and Marketing Worldwide, LIFEBRIDGE Medizintechnik.

The unique level of automation allows the system to be ready for use within 5 - 10 minutes and guides the trained user intuitively through the menu on the integrated display in five steps. The LIFEBRIDGE(R) reaches a blood flow of up to 6 l/min and is powered by a mains voltage of 110/220V AC. For mobile operation, the system can be switched to battery power for a period of up to 2.5 hours.

The LIFEBRIDGE(R) contains an automatic seven stage air safety system preventing air embolisms.

Press contact: HighTech communications GmbH Heike Mittmann Grasserstrasse 1c 80339 Munich Telephone: +49(0)89-500-778-20 Telefax: +49(0)89-500-778-77 E-Mail: h.mittmann@htcm.de

http://www.htcm.de

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us